Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-012960

Chief Executive Officer sold 18,990 shares at $14.83 ($281,644)

From the SEC's structured data for this filing

Trades in this filing

Kauffman Michael · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-18 Sale : show line 1 in the form −9,495 $14.83 $140,822 575,126 D
2021-02-18 Sale : show line 2 in the form −9,495 $14.83 $140,822 776,452 I
Open-market sales · 18,990 sh · avg $14.83 · $281,644
Loading xslF345X03/doc4.xml…